ASX
Telix Pharmaceuticals
TLX:ASX•Healthcare
Sensitive ASX Announcement
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
Published: 13/01/25, 05:10pm (AEST)•4 pages